Single dose HPV vaccine in achieving global cervical cancer elimination
- PMID: 38365404
- DOI: 10.1016/S2214-109X(24)00009-3
Single dose HPV vaccine in achieving global cervical cancer elimination
Conflict of interest statement
We declare no competing interests.
Comment on
-
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.Lancet Glob Health. 2024 Mar;12(3):e491-e499. doi: 10.1016/S2214-109X(23)00586-7. Lancet Glob Health. 2024. PMID: 38365419 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
